1–2 of 2 results for nr2e3
One Year Follow-up in a Phase 1/2 Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa
Benjamin Bakall, MD, PhD
Annual Meeting Talks
2024
Recognizable Patterns of Submacular Fibrosis in the Enhanced S-Cone Syndrome
Sawsan R Nowilaty, MD, FASRS
2021